Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: Preliminary results

This publication has 14 references indexed in Scilit:

• Four-drug sequential regimen in advanced breast cancer
  Breast Cancer Research and Treatment, 1987
• Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
  Journal of Clinical Oncology, 1987
• A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
  Journal of Clinical Oncology, 1987
• Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer
  Cancer, 1987
• Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study.
  Journal of Clinical Oncology, 1987
• High-dose chemotherapy for breast cancer.
  Journal of Clinical Oncology, 1987
• 5-Fluorouracil and High-Dose Folinic Acid as Salvage Treatment of Advanced Breast Cancer: An Update
  Oncology, 1987
• Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a southwest oncology group trial
  Cancer, 1985
• Short term high density systemic therapy for metastatic breast cancer
  Breast Cancer Research and Treatment, 1985
• The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and α-tocopherol
  European Journal of Cancer and Clinical Oncology, 1982